Annexon, Inc. Common Stock
ANNX Real Time Price USDRecent trades of ANNX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ANNX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Anti-complement factor c1q fab fragments and uses thereof Jun. 04, 2024
-
Patent Title: Inhibitors of complement factors and uses thereof Nov. 14, 2023
-
Patent Title: Anti-complement factor c1q antibodies and uses thereof May. 16, 2023
-
Patent Title: Anti-complement factor c1q antibodies and uses thereof Feb. 23, 2021
-
Patent Title: Anti-complement factor c1q fab fragments and uses thereof Jul. 28, 2020
-
Patent Title: Anti-complement factor c1q antibodies and uses thereof Mar. 17, 2020
-
Patent Title: Humanized anti-complement factor c1q antibodies Jun. 11, 2019
-
Patent Title: Anti-complement factor c1q antibodies and uses thereof Mar. 12, 2019
-
Patent Title: Anti-complement factor c1q antibodies and uses thereof Jul. 18, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ANNX in WallStreetBets Daily Discussion
Recent insights relating to ANNX
Recent picks made for ANNX stock on CNBC
ETFs with the largest estimated holdings in ANNX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ANNX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.